ICL to Acquire Lavie Bio, Enhancing Ag Tech Portfolio

ICL has signed a definitive agreement to acquire Lavie Bio, a subsidiary of Evogene Ltd., which specializes in microbiome-based agricultural products. The transaction, expected to close in Q2 2025, aims to enhance ICL’s capabilities in ag-biologicals and follows over two years of collaboration between the two companies.

Original excerpt: ICL will also acquire Evogene’s MicroBoost AI for AG platform…

Source: CropLife